Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 1/20 | 0.44 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.44 |
| ▸ | DRD1 | P21728 | 6/20 | 0.42 |
| ▸ | DRD2 | P14416 | 4/20 | 0.42 |
| ▸ | DRD4 | P21917 | 4/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.42 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.42 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29568322 | 1.00 | CHRNB2 (0.44) | CHRNB2CHRNA4DRD1DRD2DRD4 | |
| SCHEMBL14395237 | 1.00 | CHRNB2 (0.44) | CHRNB2CHRNA4DRD1DRD2DRD4 | |
| Hydrochloric Acid SCHEMBL27585427 | 0.98 | MAPT (0.44) | CHRNB2CHRNA4DRD1DRD2DRD4 | |
| Bromide SCHEMBL3966126 | 0.98 | CHRNB2 (0.42) | CHRNB2CHRNA4DRD1DRD2DRD4 | |
| SCHEMBL358171 | 0.78 | PRCP (0.58) | DRD1MAPTTSHR | |
| SCHEMBL30924714 | 0.78 | PRCP (0.58) | DRD1MAPTTSHR | |
| SCHEMBL16224765 | 0.78 | PARP1 (0.40) | CHRNB2CHRNA4CYP2D6CYP1A2HSD17B10 | |
| SCHEMBL28409392 | 0.75 | PRCP (0.46) | CYP2D6CYP1A2MAPTCYP2C19CYP2C9 | |
| SCHEMBL9009806 | 0.74 | HTR2A (0.40) | CHRNB2CHRNA4DRD1DRD2DRD4 | |
| SCHEMBL28404711 | 0.73 | PRCP (0.48) | HSD17B10ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117729945-A | Fragrance composition, method of making and articles comprising the same | 埃克苏德公司 | 2024-03-19 | — | — | CN | claimed |
| CN-114728968-A | Condensed pyridone compound and preparation method and application thereof | 上海济煜医药科技有限公司 | 2022-07-08 | — | — | CN | claimed |
| WO-2021052499-A1 | FUSED PYRIDONE COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 上海济煜医药科技有限公司 | 2021-03-25 | — | — | WO | claimed |
| US-8163753-B2 | 2-(4-(4-(4-chlorophenyl)oxazol-2-yl)phenoxymethyl)-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole; bactericide; excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2012-04-24 | — | — | US | claimed |
| EP-1648886-B1 | BENZOXAZINONE-DERIVED SULFONAMIDE COMPOUNDS, THEIR PREPARATION AND USE AS MEDICAMENTS | ESTEVE LABOR DR (ES) | 2009-12-09 | — | — | EP | claimed |
| US-7582720-B2 | Transparent polycarbonate, poly(meth)acrylate core/shell particles; free of anthanthrones, anthraquinones, benzimidazoles, diketopyrrolopyrroles, isoindolinols, perinones, perylenes, phthalocyanines, quinacridones, quinophthalones which prevents degradation of polycarbonate; diffuser sheets | BAYER MATERIAL SCIENCE AG (DE) | 2009-09-01 | — | — | US | claimed |
| JP-2008531793-A | — | — | 2008-08-14 | — | — | JP | claimed |
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | OTSUKA PHAMACEUTICAL CO., LTD. (JP) | 2008-05-22 | — | — | US | claimed |
| EP-1858979-A1 | LIGHT-SCATTERING SHAPED ARTICLES OF HIGH LIGHT TRANSMISSION AND THE USE THEREOF IN FLAT SCREENS | Bayer MaterialScience AG (DE) | 2007-11-28 | — | — | EP | claimed |
| WO-2006094624-A1 | LIGHT-SCATTERING SHAPED ARTICLES OF HIGH LIGHT TRANSMISSION AND THE USE THEREOF IN FLAT SCREENS | BAYER MATERIALSCIENCE AG (DE) | 2006-09-14 | — | — | WO | claimed |
| US-20060198999-A1 | Transparent polycarbonate, poly(meth)acrylate core/shell particles; free of anthanthrones, anthraquinones, benzimidazoles, diketopyrrolopyrroles, isoindolinols, perinones, perylenes, phthalocyanines, quinacridones, quinophthalones which prevents degradation of polycarbonate; diffuser sheets | BAYER MATERIALSCIENCE AG (DE) | 2006-09-07 | — | — | US | claimed |
| EP-1678185-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-07-12 | — | — | EP | claimed |
| WO-2005042542-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-05-12 | — | — | WO | claimed |
| EP-4366733-A1 | TETRAHYDROPYRAZOLOPYRIDINE-ANALOG LIGANDS OF NLRX1 AND USES THEREOF | LANDOS BIOPHARMA, INC. (US) | 2024-05-15 | — | — | EP | disclosed |
| EP-3927427-B1 | LANTHIONINE C-LIKE PROTEIN 2 LIGANDS, CELLS PREPARED THEREWITH, AND THERAPIES USING SAME | NIMMUNE BIOPHARMA INC (US) | 2024-02-07 | — | — | EP | disclosed |
| CN-117500785-A | Azetidinyl-containing carboxylic acid compounds for the treatment of neurodegenerative diseases | 细胞基因公司 | 2024-02-02 | — | — | CN | disclosed |
| EP-0135280-B1 | NEW POLYMERIZATION PROCESS AND POLYMERS PRODUCED THEREBY | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1993-05-12 | — | — | EP | disclosed |
| US-4581429-A | Polymerization process and polymers produced thereby | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANIZATION (AU) | 1986-04-08 | — | — | US | disclosed |
| EP-0135280-A2 | New polymerization process and polymers produced thereby | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1985-03-27 | — | — | EP | disclosed |
| EP-0002792-A1 | 3-Aminopropoxyaryl derivatives, their preparation and pharmaceutical compositions containing them | SANDOZ AG (CH) | 1979-07-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | NR2C2, NR0B2, NR4A2 | CHRNB2 1347/4885CHRNA4 1594/4885DRD1 239/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.